NEW YORK, NY / ACCESSWIRE / November 30, 2017 / Universal Technical Institute, Inc. (NYSE: UTI) will be discussing their earnings results in their Q4 Earnings Call to be held on November 30, 2017 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/2414.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 483302

NEW YORK, NY / ACCESSWIRE / November 30, 2017 / Nutanix, Inc. Class A (NASDAQ: NTNX) will be discussing their earnings results in their Q1 Earnings Call to be held on November 30, 2017 at 4:30 PM Eastern Time.

To listen to the event live or access a replay of the call – visit https://www.investornetwork.com/company/83199.

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on the what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

ReleaseID: 483303

Company Subscribes to OTC Disclosure and News Service to Qualify for Current Information Tier by Year End 2017

LAS VEGAS, NV / ACCESSWIRE / November 30, 2017 / Pulse Evolution Corporation (OTC PINK: PLFX), a recognized pioneer and leading developer of hyper-realistic digital humans for holographic live performances, virtual reality, and augmented reality, today announced its plans to qualify for the OTC Current Information Tier, pursuant to the Alternative Reporting Standard of OTC Markets.

The Company has subscribed to the OTC Disclosure and News Service and intends to qualify for the Current Information Tier with the filing, prior to December 31, 2017, of its quarterly financial reports for the periods ending December 31, 2015 through September 30, 2017. The Company was a previously a “voluntary filer,” under Section 13 and Section 15(d) of the Securities Exchange Act of 1934, with its last 10-Q filing representing the first quarter of fiscal year 2016, ending September 30, 2015, and subsequent events as of the date of the filing on August 10, 2016.

About Pulse Evolution Corporation

The Company is a recognized pioneer and leading developer of hyper-realistic digital humans for entertainment, virtual reality, augmented reality, and artificial intelligence. Pulse is most popularly known for producing the animated digital human likeness of the late Michael Jackson that appeared in a live performance of the Billboard Music Awards on May 18, 2014, seen by more than 11 million television viewers and generating more than 2,400 news articles and 98 billion Internet impressions.

Founded by the world’s leading executives and producers of photorealistic digital humans, such as the lead character from the film “The Curious Case of Benjamin Button” and the concert experience, “Tupac at Coachell,” Pulse Evolution is currently developing computer-generated digital humans for entertainment and media applications, such as holographic live performances, virtual reality, augmented reality, and artificial intelligence. The Company has a multi-year revenue share agreement with the Estate of Michael Jackson, and intellectual property relationships and rights with other leading global celebrities, and is principally focused on generating revenues from these relationships.

The Company sees digital humans emerging as ubiquitous in society, culture and industry. They will not only perform for audiences on stage or in film, but they will also represent individual consumers as digital likeness avatars, in realistic and fantasy form, appearing and interacting on the consumer’s behalf in electronic and mobile communication, social media, video games and virtual reality. Future digital humans will provide a relatable human interface for artificial intelligence applications, “thinking” machine systems that, through the Company’s technology, will appear as realistic communicating humans in mobile devices, digital signage, classrooms and through lightweight wearable augmented reality glasses and virtual reality headsets. The Company’s long-term goal is to be the “face” of artificial intelligence, to provide a human form to interactive artificially intelligent computer beings.

Pulse is headquartered in Las Vegas, Nevada. Please visit www.pulse.co.

Forward-Looking Statements Disclaimer:

Certain statements contained in this news release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995. Forward-looking statements contained in this release relate to, among other things, the timing and potential success of new projects, productions, product releases, future operating results, and the Company’s leadership in the digital production, VR and AR industry. These forward-looking statements are generally identified by words such as “believes,” “may,” “expects,” “anticipates,” “should,” and other similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based on the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other items described in more detail in the Company’s filings, including Annual and Quarterly reports, with the United States Securities and Exchange Commission (copies of which may be obtained at www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change significantly. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

SOURCE: Pulse Evolution Corporation

ReleaseID: 483317

NEW YORK, NY / ACCESSWIRE / November 30, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has issued an update on PotNetwork Holding, Inc.

The report is available here: POTN November Update Note.

PotNetwork Holding (OTC PINK: POTN), through its subsidiary Diamond CBD Inc., focuses on research, development, and sale of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. CBD is one of the more than 85 cannabinoids identified in marijuana and hemp plants and is non-psychoactive with wide array of therapeutic benefits. Hemp-derived CBDs provides a legal alternative to marijuana-based CBD (which is banned at federal level) and allows the consumer to enjoy CBD without the risk of getting high and breaking any federal laws. Hemp-derived CBD market is projected to grow at a CAGR of ~53% till 2020, positioning it as the fastest growing sub-segment within the multi-billion-dollar legal cannabis and hemp market. Diamond CBD continues to report robust top line growth, as indicated by recent 3Q17 sales and continued momentum in October. We see POTN as a speculative growth company focused on the burgeoning legal cannabis and hemp market targeting the fastest growing sub-segment (hemp derived CBD). Upcoming catalysts new product launches, aggressive marketing initiatives and entry into new markets (specifically China).

Highlights from the update include:

We are increasing our price target for POTN following encouraging results since our initiation of coverage. POTN results have included robust top line growth, as well as a reduction in shares outstanding. The company now appears to be tracking ahead of our initial results, with significant sales momentum in a structural growth market.

Highlights of recent developments at POTN include:

On November 2, 2017, POTN pre-announced positive 3Q17 sales results with revenue of approximately $4.4mn, up 29% sequentially from $3.2mn in 2Q17.
Momentum appears to have continued for the company as management announced October sales came in at $1.7mn, up 40%+ from September.
On November 27, 2017, POTN retired 300mn common shares held by principal shareholders, reducing common shares outstanding; the shares will be exchanged for non-trading preferred shares.
The company appointed a new PCAOB accounting firm registered in South Florida, East West Accounting Services, LLC, to deliver a detailed review and audit of recent revenues results.
In October, POTN appointed Dr. Richard Goulding, MD, as its new CEO. According to the announcement, Dr. Goulding will bring the company key insights on the medical benefits of cannabidiol (CBD) from a physician’s standpoint, including insights on research for CBD as a treatment for pain management and other medical applications as the company expands its presence in the market. Former CEO Gary Blum will remain with POTN as Chairman of the Board of Directors.

Increasing price target to $0.40

We are increasing our target to $0.40 following recent results and apparent sales momentum at the company as it expands its product offerings and distribution. The $0.40 target suggests a valuation of 4.7x 2018E revenues of 22.8mn and 40x estimated 2018E EPS of $0.01.

Please review important disclosures on our website at www.seethruequity.com.

About PotNetwork Holding, Inc.

PotNetwork Holding Inc. is a publicly traded company that acts as a holding company for its subsidiary, First Capital Venture Co., the owner of Diamond CBD, Inc. Diamond CBD focuses on the research, development, and multi-national marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. For more information, visit www.diamondcbd.com.

About SeeThruEquity

Since its founding in 2011, SeeThruEquity has been committed to its core mission: providing impactful, high quality research on underfollowed smallcap and microcap equities. SeeThruEquity has pioneered an innovative business model for equity research that is not paid for and is unbiased. SeeThruEquity is the host of acclaimed investor conferences that are the ultimate event for publicly traded companies with market capitalizations less than $1 billion.

SeeThruEquity is approved to contribute its research reports and estimates to Thomson One Analytics (First Call), the leading estimates platform on Wall Street, as well as Capital IQ and FactSet. SeeThruEquity maintains one of the industry’s most extensive databases of opt-in institutional and high net worth investors. The firm is headquartered in Midtown Manhattan in New York City.

For more information, visit www.seethruequity.com.

Contact:

Ajay Tandon
SeeThruEquity
info@seethruequity.com

SOURCE: SeeThruEquity

ReleaseID: 483318

MOSCOW, RUSSIA / ACCESSWIRE / November 30, 2017 / Mobile TeleSystems PJSC (“MTS”) (FRA: MKY) has become the first company in Russia to partner with Microsoft to offer Azure hybrid cloud services for corporate clients across the country.

The integrated Microsoft Azure Stack system, hosted in MTS data centers, will allow business customers to create modern hybrid applications combining the capacities of our local data services with global cloud functionality. Furthermore, we will offer Russian B2B clients a choice of where to deploy their new virtual machines and store data – in their own or partner data center within the territory of Russia or in a global cloud.

The solution allows business customers to use the latest technologies in full compliance with Russian corporate requirements for IT security, as well as to enjoy enhanced applications with high response speeds, giving the opportunity to create a real hybrid cloud and be a platform for hyper-convergent infrastructure.

Microsoft Azure services and Azure Stack facilities on MTS will be available to Russian business customers in commercial operation from the beginning of 2018. We will provide all the key global Azure services, with localization in Russia, including Iaas, PaaS, Big Data, various types of storage, hybrid variants of redundant, fault-tolerant virtual data centers, lease of licenses, and other services that our corporate clients demand.

Vladimir Khrenkov, Director for Innovation Development at MTS, comments on the deal saying, “Demand for virtual products is steadily growing by 20-35% each month. Our customers are interested in creating hybrid systems. Every other company that asks us for virtual infrastructure services also requests the possibility of interaction between the resources of private and public clouds. The partnership with Microsoft will allow MTS to meet the customer’s demand and expand the range of its own cloud solutions for the corporate segment.”

SOURCE: Mobile TeleSystems PJSC

ReleaseID: 483313

NEW YORK, NY / ACCESSWIRE / November 30, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Acorda Therapeutics, Inc. (“Acorda” or the “Company”) (NASDAQ: ACOR) and certain of its officers, on behalf of a class who purchased Acorda securities between April 18, 2016, and November 14, 2017, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acor.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws.

Acorda is a biotechnology company with a focus on the identification, development, and commercialization of therapies for neurological disorders. On January 19, 2016, Acorda announced an agreement to acquire Biotie Therapies Corporation (“Biotie”) for approximately $363 million (the “Biotie Acquisition”). In its press release announcing the Biotie Acquisition, Acorda advised investors, inter alia, that the Company “will obtain worldwide rights to tozadenant, an oral adenosine A2a receptor antagonist currently in Phase 3 development in Parkinson’s disease (PD).” On April 18, 2016, Acorda acquired approximately 93% of the fully diluted capital stock of Biotie. In September 2016, Acorda completed the Biotie Acquisition.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) tozadenant entailed significant undisclosed safety risks; (2) accordingly, the Company had overstated tozadenant’s approval prospects and commercial viability; (3) for the foregoing reasons, the Company had likewise overstated the benefits of the Biotie Acquisition; and (4) consequently, Acorda’s shares traded at artificially inflated prices during the Class Period.

On November 15, 2017, Acorda disclosed the deaths of several patients in the Company’s final-stage studies of tozadenant. Acorda advised investors that it had paused new enrollment in the drug’s long-term safety studies, pending further discussion with the independent Data Safety Monitoring Board and the U.S. Food and Drug Administration. Following this news, Acorda stock dropped $11.20 per share, or 39.72%, to close at $17.00 on November 15, 2017.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: www.bgandg.com/acor, or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Acorda, you have until January 17, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 482336

Company Expects Record Second Quarter Fiscal 2018 Financial Results

LOS ANGELES, CA / ACCESSWIRE / November 30, 2017 / Atlas Technology International, Inc. (OTCQB: ATLT), a rapidly growing designer, manufacturer, and distributor of touchscreen devices, today announced that it has canceled nearly half of its total shares outstanding, all its preferred stock and any remaining convertible debentures as part of its overall plan to restructure the Company into a significantly more profitable and cash-rich entity for its shareholders. The Company today also announced that it expects to report record revenues and earnings when it reports its second quarter and first half of fiscal 2018 financial results. The Company noted that due to the cancellation of the substantial amount of stock – all of which was held by insiders – will, of course, have a significantly positive impact on its future earnings per share and overall valuation. The share cancellation decreased the Company’s total shares outstanding from 56 million shares outstanding to approximately 32 million shares outstanding.

“During the first half of this year, we expanded our organization into the United States to better serve our customers in what is by far the largest and fastest growing market for touchscreen devices in the world,” said Matthew Tsai, Chief Executive Officer of Atlas Technology International, Inc. “This strategic move combined with our decision to cancel nearly half our total shares outstanding will further solidify Atlas Technology’s position as one of the fastest growing, streamlined and innovative players in the world’s multi-billion dollar and growing touch screen industry. With this foundation underneath us, we can now begin to truly focus on building earnings per share growth and, as a result, significant enhancements in shareholder value,” concluded Mr. Tsai.

Conference Call and Webcast Information

Title

Atlas to Discuss Share Cancellation and Fiscal 2018 Guidance

Presentation Type

Audio Webcast

Event Date

2017-11-30 13:00:00 Eastern

Participant Numbers

Toll-Free: 877-407-9210

Toll: 201-689-8049

Replay Number

877-481-4010 | 919-882-2331 #23085

Teleconference Replay Expiration

2017-12-07 13:00:00

Event Link

http://www.investorcalendar.com/event/23085

Webcast Replay Expiration

2018-03-02 13:00:00

To be added to the Company’s investor lists, please contact Bill Miller at Investor Relations Partners at 844-565-5665 or via email at bmiller@irpartnersinc.com.

About Atlas Technology International, Inc.

Atlas Technology International, Inc. (OTCQB: ATLT) is a leading designer, manufacturer, and distributor of touchscreen devices to consumer electronic producers all over the world. Their products power the interface to a wide array of smart devices including GPS systems, point of sale machines, hospitality and medical devices and small appliances. For further information on Atlas Technology International, please visit our website at www.atlastechintl.com.

(This Press Release may contain certain forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Atlas Technology International, Inc. has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential,” and similar expressions. These statements reflect Atlas Technology International’s current beliefs and are based on information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause Atlas Technology International’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Atlas Technology International undertakes no obligation to update or provide advice in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.)

SOURCE: Atlas Technology International, Inc.

ReleaseID: 483310